Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
clinical trials
life sciences
national blog main
boston blog main
fda
national top stories
roche
san francisco top stories
boehringer ingelheim
boston top stories
national
novartis
san francisco blog main
abbvie
actavalon
acute myeloid leukemia
aileron therapeutics
alexion pharmaceuticals
alnylam pharmaceuticals
ame cloud ventures
american diabetes association
aprea therapeutics
arimoclomol
arnold levine
baker brothers
billy dunn
biogen
biotech ipos
boston
cancer
cancer diagnostics
cdg therapeutics
cirina
clostridium difficile
colleen cutcliffe
computational biology
daiichi sankyo
deals
decheng capital
What
intended
4
×
blood
drug
roche
approved
atrophy
available
balance
biome
broader
cancer
caught
causing
company
daily
detect
developing
diabetes
dicerna
disease
evrysdi
eye
eyes
fda
files
firms
food
friday
gene
grail
green
healthy
hepatitis
home
hormone
include
investors
ipo
join
launch
Language
unset
Current search:
intended
×
biotech
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes